.6 0.4 0.two 0.010-EF** ** **** ** ** *10-10-10-10-10-10-[Acetylcholine], (M)[Acetylcholine], (M
.6 0.four 0.two 0.010-EF** ** **** ** ** *10-10-10-10-10-10-, (M), (M)E150 Normalized FrequencynFREQFFractional Pump...
LM14 cells (Figure 5C), or NVP-BE235 plus imatinib in BCR-ABL1 good
LM14 cells (Figure 5C), or NVP-BE235 plus imatinib in BCR-ABL1 constructive K562 cells (Figure...
HIV infectionor TDF.103,104 An IVR based on DPV, a potent NNRTI
HIV infectionor TDF.103,104 An IVR based on DPV, a potent NNRTI, has also been...
Temic side-effects and skin atrophyPharmaceutics 2013,that is commonly associated with other
Temic side-effects and skin atrophyPharmaceutics 2013,that is commonly associated with other topical treatments such...
D in a chemical hood for 3 hours. Three wash steps were
D in a chemical hood for 3 hours. Three wash steps were then performed....
Ls in time course experiments when G1 cells were released into
Ls in time course experiments when G1 cells were released into MMS-containing media (Figure...
S bound MT2, but only [125I]-2IMLT and [125I]-SD
S bound MT2, but only -2IMLT and -SD6 bound MT1. The pKb and Bmax...
DSingle-feedlot ZH datasetMulti-feedlot ZH datasetDatasetExposedCohort0.42, 0.Discussion95 confidence limits0.0.40, 0.0.0.44, 1.Mortality in Cattle
DSingle-feedlot ZH datasetMulti-feedlot ZH datasetDatasetExposedCohort0.42, 0.Discussion95 confidence limits0.0.40, 0.0.0.44, 1.Mortality in Cattle Administered b...
F, Burchard G-D, Andriano K, Lef re G, De Palacios PI
F, Burchard G-D, Andriano K, Lef re G, De Palacios PI, Genton B: Therapy...
E the LTP-facilitating impact of H,S. DTP (1 mM) was utilized
E the LTP-facilitating impact of H,S. DTP (one mM) was utilized through timeindicated strong...